Gao et al. found that the number methylation-positive SHOX2 and RASSF1A patients increased with clinicopathological stage of the disease, and the age of the patients affected by lung adenocarcinoma [6]. This evidence concerns the gene SHOX2 and lung adenocarcinoma.